根据协议条款,若发生特定终止事件,RAPT Therapeutics Inc.将需向制药巨头葛兰素史克支付一笔高达7840万美元的现金终止费用。此项安排凸显了双方合作协议中关于提前解约的财务约束机制。
根据协议条款,若发生特定终止事件,RAPT Therapeutics Inc.将需向制药巨头葛兰素史克支付一笔高达7840万美元的现金终止费用。此项安排凸显了双方合作协议中关于提前解约的财务约束机制。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.